EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
21 11-2023

BRAINTEASER Webinar: Women in Multiple Sclerosis

2023-11-21T13:28:27+00:0021-11-2023|

Join us for a online event that focuses on Women in Multiple Sclerosis (MS). This webinar will provide valuable insights and information about the unique challenges and experiences faced by women with MS. Gain knowledge from renowned experts in the field and hear inspiring stories from women who are managing their MS. Don't miss [...]

17 07-2023

Unleashing the IDPP@CLEF Potential: Assessing Predictive Algorithms and Enabling Data Sharing for Enhanced Research

2023-07-17T12:39:33+00:0017-07-2023|News|

Each year, the BRAINTEASER project organizes an open evaluation challenge, called iDPP@CLEF (Intelligent Disease Progression Prediction), to involve research groups from academia and industry in the assessment of the performance of their AI algorithms to predict the progression of ALS and MS. These challenges are open to anyone wishing to participate and they are [...]

9 03-2023

Look back at the BRAINTEASER Mid Term workshop

2023-03-21T15:41:48+00:0009-03-2023|News|

A European digital health project that develops new tools to help patients with amyotrophic lateral sclerosis and multiple sclerosis BRAINTEASER mid-term workshop took place on 28 February 2023 in the prestigious location of the University of Padua Botanical Garden, Italy and was attended by almost 80 participants. The organization of the event came at the [...]

3 01-2023

BRAINTEASER Mid Term Workshop: Data science and artificial intelligence for supporting the care and cure of amyotrophic lateral sclerosis and multiple sclerosis patients

2023-02-13T13:37:20+00:0003-01-2023|

BRAINTEASER is a data science project, which the European Brain Council is part of, employs AI-based clinical software and mobile apps to support patients with amyotrophic lateral sclerosis and multiple sclerosis, their clinicians and families. We have developed a prototype app-based solution with the aim of bridging the gap between hospital- and [...]

25 05-2021

Open co-design workshop on next generation tools to manage Amyotrophic Lateral Sclerosis and Multiple Sclerosis

2021-05-31T14:33:05+00:0025-05-2021|

Started on January 2021, the 4 years Horizon 2020 BRAINTEASER project seeks to exploit the value of artificial intelligence, big data—including those related to health, lifestyle habits and environment—, low-cost sensors and smart apps to support patients living with amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) and their caregivers. Its goal is to develop [...]

28 01-2021

Event report: Virtual workshop on the off-label use of medicines in Sweden and Norway

2021-02-18T13:43:47+00:0028-01-2021|News|

Striking the right balance between timely access to medicines and maintaining the highest standards of patient safety. Introduction to the event The event, hosted by the Swedish Brain Foundation, the Norwegian MS Association and the European Brain Council was held virtually on 24 November 2020. It brought together over 80 representatives from Norway and [...]

28 01-2021

EU-Funded BRAINTEASER project, bringing AI home for better care of ALS and MS, kicks off!

2022-04-14T12:42:44+00:0028-01-2021|News|

Officially started on the 1st of January 2021, the H2020 BRAINTEASER project kicked off its operational activities on 28 and 29 January, at the presence of its project officer Mr Tobias Wiesenthal, Head of Sector 'Research and Innovation' at DG CONNECT.H.3 – eHealth, Well-Being and Ageing. All the 11 partners, a multidisciplinary gender-balanced consortium [...]

Go to Top